Flow cytometric analysis
After transfection of siRNAs for 48 h, cells (2.0 × 10 6 cells/mL) were dissociated in FACS buffer (1 × PBS supplemented with 2% FBS), incubated with APC-conjugated anti-CD133 antibody for 10 min on ice, and analyzed using a FACS Calibur flow cytometer (BD Biosciences). Unstained cells were used as a gating control. The data was analyzed using FlowJo 8.8.4 software. Three independent assays were performed for confirmation.
Survival analysis
From the TCGA dataset in Oncomine, we obtained overall survival follow-up times (days) and survival statuses for 447 of 532 patients. We defined two groups based on Glo1 expression: Glo1 high (log2 median centered intensity > 0) and Glo1 low (log2 median centered intensity < 0) (Supplementary Figure 1A) . From the METABRIC dataset in cBioportal, we obtained the overall survival (months) and overall survival status for 1904 patients. We defined another two groups based on Glo1 expression: Glo1 high (z-score > 0) and Glo1 low (z-score < 0) (Supplementary Figure 1B) . Differences between overall survival in Kaplan-Meier analyses were determined using the log-rank test. Multivariable Cox regression was used to evaluate the influence of Glo1 expression with age and tumor stage as confounding factors. All statistical analyses were performed using R version 3.4.1 (R Foundation for Statistical Computing, Vienna, Austria).
Analysis of TCGA dataset of several cancers
The Cancer Genome Atlas (TCGA) dataset was downloaded from Oncomine (https://www.oncomine.org, Compendia Bioscience, Ann Arbor, MI, USA). Levels of GLO1 mRNA expression in colon, lung, renal, uterine (reporter: A_32_P53822), brain, and ovarian cancer and leukemia (reporter: 200681) tissues and the corresponding normal tissues were displayed using log2 median-centered ratio boxplots for normal vs. cancer tissue. The p values are calculated using the Mann-Whitney U test. *** p < 0.001, n.s. = not significant; Mann-Whitney U test. 
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